A1.2 High Throughput analysis of IGG fab glycosylation reveals differences between RA-patients and healthy controls during pregnancy and after delivery
A1.2 High Throughput analysis of IGG fab glycosylation reveals differences between RA-patients and healthy controls during pregnancy and after delivery